Mohr, P., Scherrer, E., Assaf, C., Bender, M., Berking, C., Chandwani, S., . . . Weichenthal, M. (2022). Real-world therapy with pembrolizumab: Outcomes and surrogate endpoints for predicting survival in advanced melanoma patients in Germany. Cancers, 14(7), . https://doi.org/10.3390/cancers14071804
Chicago-Zitierstil (17. Ausg.)Mohr, Peter, et al. "Real-world Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany." Cancers 14, no. 7 (2022). https://doi.org/10.3390/cancers14071804.
MLA-Zitierstil (9. Ausg.)Mohr, Peter, et al. "Real-world Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany." Cancers, vol. 14, no. 7, 2022, https://doi.org/10.3390/cancers14071804.